Peter Popovič
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Biotechnology top 5%
- Microbial Inactivation Methods
Papers in
- Surgery 8
- Abdominal vascular conditions and treatments 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Co-authors
- Rok Dežman (8 shared papers)Olivier Rosmorduc (1 shared paper)Antonio Gasbarrini (1 shared paper)Peter Malfertheiner (1 shared paper)Eckart Schott (1 shared paper)Enrico N. De Toni (1 shared paper)Markus Peck‐Radosavljevic (1 shared paper)Max Seidensticker (1 shared paper)
In The Last Decade
Peter Popovič
27 papers receiving 571 citations
Peter Popovič's Hit Papers
Peers
Comparison fields: 5 of 55
- Hepatology 235
- Biotechnology 123
- Internal Medicine 26
- Pulmonary and Respiratory Medicine 84
- Epidemiology 83
Countries citing papers authored by Peter Popovič
This map shows the geographic impact of Peter Popovič's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Popovič with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Popovič more than expected).
Fields of papers citing papers by Peter Popovič
This network shows the impact of papers produced by Peter Popovič. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Popovič. The network helps show where Peter Popovič may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Popovič, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma Hit paper breakdown → | 2019 | 249 |
| 2 | 2018 | 73 | |
| 3 | 2020 | 30 | |
| 4 | 2013 | 27 | |
| 5 | 2020 | 26 | |
| 6 | 2015 | 18 | |
| 7 | 2016 | 16 | |
| 8 | 2010 | 14 | |
| 9 | 2020 | 12 | |
| 10 | 2009 | 12 | |
| 11 | 2020 | 11 | |
| 12 | 2018 | 11 | |
| 13 | 2015 | 11 | |
| 14 | Contrast-enhanced ultrasound for assessment of therapeutic response after percutaneous radiofrequency ablation of small renal tumors. | 2016 | 10 |
| 15 | 2022 | 8 | |
| 16 | 2021 | 8 | |
| 17 | 2017 | 8 | |
| 18 | 2019 | 8 | |
| 19 | 2015 | 7 | |
| 20 | 2016 | 6 |
About Peter Popovič
Peter Popovič is a scholar working on Surgery, Hepatology, Pulmonary and Respiratory Medicine, Internal Medicine and Biotechnology, having authored 30 papers that have together received 578 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Microbial Inactivation Methods (4 papers), Renal cell carcinoma treatment (3 papers), Acute Ischemic Stroke Management (2 papers), Hormonal Regulation and Hypertension (2 papers), Acute Myocardial Infarction Research (2 papers) and Abdominal vascular conditions and treatments (2 papers). The work is most often cited by research in Hepatology (235 citations), Biotechnology (123 citations), Internal Medicine (26 citations), Pulmonary and Respiratory Medicine (84 citations) and Epidemiology (83 citations). Peter Popovič has collaborated with scholars based in Slovenia, Belgium and Spain. Frequent co-authors include Rok Dežman, Olivier Rosmorduc, Antonio Gasbarrini, Peter Malfertheiner, Eckart Schott, Enrico N. De Toni, Markus Peck‐Radosavljevic, Max Seidensticker, Irene Bargellini and Chris Verslype. Their work appears in journals such as Endocrine Connections, BMC Gastroenterology, CardioVascular and Interventional Radiology, Cancers and Radiology and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.